deltatrials
Terminated NA NCT00141596

Extracellular Fluid in Resistant Hypertension

A Study to Investigate the Contribution of Extracellular Fluid Volume Expansion to Drug Resistant Hypertension

Sponsor: St George's, University of London

Conditions Hypertension
Interventions Amiloride 5 mg bd Cardura XL 4 mg bd Furosemide 40 mg bd
Updated 5 times since 2017 Last updated: Jun 5, 2015 Started: Jul 31, 2003 Completion: Oct 31, 2006

Listed as NCT00141596, this NA trial focuses on Hypertension and remains terminated or withdrawn. Sponsored by St George's, University of London, it has been updated 5 times since 2003, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • St George's, University of London
Data source: St George's, University of London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • London, United Kingdom